Bosutinib

Tags: Drug.

Bosutinib (rINN/USAN; codenamed SKI-606 marketed under the trade name Bosulif) is a tyrosine kinase inhibitor undergoing research for use in the treatment of cancer.Originally synthesized by Wyeth it is being developed by Pfizer.

thumbnail

ATC prefix

L01

ATC suffix

XE14

CAS number

380843-75-4

ChEBI

39112

FDA UNII code

5018V4AEZ0

IUPAC name

4-[(24-dichloro-5-methoxyphenyl)amino]-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

PubChem

5328940